EVGN today
$0.27-$0.04 (-11.73%)close Nov 6, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourExpanding
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns up above $0.47
Key levels
Resistance$0.39
Resistance$0.35
Latest news & SEC filings
ProductEvogene names a target for its in-house drug discovery work
NewsEverGen Infrastructure reports record RNG output for Q3 2026
All EVGN news →About Evogene
Evogene is a life sciences company that applies computational biology to develop products across crop science, medicine, and industrial uses. Its subsidiaries include AgPlenus, focused on crop protection chemistry; Ag-Seeds, which develops improved plant traits; Casterra, which produces castor bean seeds as feedstock for industrial oil; and Biomica, which works on microbiome-based therapies. The company is based in Israel and partners with agricultural and pharmaceutical firms to develop and commercialize its product candidates.
Based on the company's 20-F filed Mar 26, 2026.
Nasdaq · Basic Materials
Evogene Ltd. (EVGN)
What Is the Price Target for EVGN?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is EVGN a Buy or Sell Right Now?
Thesis
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for EVGN.
Start Free Trial →Is EVGN Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
5
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with EVGN?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →EVGN Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for EVGN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for EVGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:21:11 | $0.25 | 1,009 | $$252 | SELL |
| 20:55:23 | $0.28 | 10,534 | $$3K | SELL |
| 20:50:04 | $0.27 | 1,900 | $$514 | SELL |
| 20:50:04 | $0.27 | 1,002 | $$271 | SELL |
| 20:30:56 | $0.28 | 3,500 | $$963 | BUY |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Evogene Ltd. (EVGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →EVGN — frequently asked questions
What is EVGN stock price today?
Evogene Ltd. (EVGN) is at $0.27, down 11.73% (-$0.04) at the Nov 6, 2026 close.
Why is EVGN stock moving today?
Latest EVGN news — Oct 28, 2026: Evogene names a target for its in-house drug discovery work · Oct 24, 2026: EverGen Infrastructure reports record RNG output for Q3 2026
Did EVGN beat earnings?
EVGN last reported on Aug 18, 2026: EPS -$0.13 vs -$0.27 expected — a beat of 51.9%.
What are EVGN support and resistance levels?
Resistance: $0.35, $0.39, $0.47.
What are insiders doing with EVGN?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on EVGN?
Oct 28, 2026: Evogene names a target for its in-house drug discovery work · Oct 24, 2026: EverGen Infrastructure reports record RNG output for Q3 2026